- Home
- DXCM vs LII Comparison
DXCM vs LII Comparison
Compare DXCM & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- LII
- Stock Information
- Founded
- DXCM 1999
- LII 1895
- Country
- DXCM United States
- LII United States
- Employees
- DXCM N/A
- LII N/A
- Industry
- DXCM Medical/Dental Instruments
- LII Industrial Machinery/Components
- Sector
- DXCM Health Care
- LII Industrials
- Exchange
- DXCM Nasdaq
- LII Nasdaq
- Market Cap
- DXCM 28.0B
- LII 21.7B
- IPO Year
- DXCM 2005
- LII 1999
- Fundamental
- Price
- DXCM $79.53
- LII $666.61
- Analyst Decision
- DXCM Buy
- LII Buy
- Analyst Count
- DXCM 17
- LII 14
- Target Price
- DXCM $101.29
- LII $577.08
- AVG Volume (30 Days)
- DXCM 4.0M
- LII 257.4K
- Earning Date
- DXCM 10-24-2024
- LII 10-23-2024
- Dividend Yield
- DXCM N/A
- LII 0.69%
- EPS Growth
- DXCM 83.21
- LII 38.78
- EPS
- DXCM 1.67
- LII 21.04
- Revenue
- DXCM $3,954,000,000.00
- LII $5,151,100,000.00
- Revenue This Year
- DXCM $13.10
- LII $5.80
- Revenue Next Year
- DXCM $14.79
- LII $7.02
- P/E Ratio
- DXCM $46.77
- LII $31.70
- Revenue Growth
- DXCM 16.19
- LII 4.68
- 52 Week Low
- DXCM $62.34
- LII $405.65
- 52 Week High
- DXCM $142.00
- LII $682.50
- Technical
- Relative Strength Index (RSI)
- DXCM 66.34
- LII 65.78
- Support Level
- DXCM $72.51
- LII $655.44
- Resistance Level
- DXCM $79.37
- LII $673.96
- Average True Range (ATR)
- DXCM 2.81
- LII 12.70
- MACD
- DXCM 0.47
- LII 3.89
- Stochastic Oscillator
- DXCM 97.07
- LII 81.82
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2023, residential HVAC was 68% of sales and commercial HVAC and Heatcraft refrigeration was 32% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.